Cargando…
Heart failure outcomes and Covid-19
Pre-existing heart failure (HF) in diagnosed patients with coronavirus disease 2019 (COVID-19) is associated with a close to two-fold increased mortality rate compared to COVID-19 patients without prior HF history. Moreover, based both on biomarker as well as imaging findings, widespread endothelial...
Autores principales: | Standl, Eberhard, Schnell, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020602/ https://www.ncbi.nlm.nih.gov/pubmed/33831494 http://dx.doi.org/10.1016/j.diabres.2021.108794 |
Ejemplares similares
-
Updates on cardiovascular outcome trials in diabetes
por: Schnell, Oliver, et al.
Publicado: (2017) -
Current perspectives on cardiovascular outcome trials in diabetes
por: Schnell, Oliver, et al.
Publicado: (2016) -
Correction to: Updates on cardiovascular outcome trials in diabetes
por: Schnell, Oliver, et al.
Publicado: (2017) -
Comparison of mechanisms and transferability of outcomes of SGLT2 inhibition between type 1 and type 2 diabetes
por: Schnell, Oliver, et al.
Publicado: (2020) -
The Munich Myocardial Infarction Registry: Translating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, pre-diabetes, and cardiovascular disease into clinical practice
por: Schnell, Oliver, et al.
Publicado: (2009)